Miconvey is pleased to announce that the QELC Aeris Universal Endoscopic Linear Cutting Stapler has received CE Certification, marking an important step in the product’s international regulatory development and market expansion. The certification confirms that QELC Aeris meets applicable European requirements for medical device safety, quality, and performance, providing surgeons, hospitals, and distribution partners with greater confidence as the product enters CE-recognized markets.
Endoscopic linear stapling is already a well-established technology in laparoscopic surgery. In such a mature and competitive field, the real value of a device is not in claiming to reinvent stapling, but in improving the details that matter during routine surgical use: stable compression, predictable firing, reliable staple formation, efficient cartridge management, and practical cost control. QELC Aeris was developed around these clinical and operational needs, offering a manual stapling platform designed for consistency, usability, and efficiency in minimally invasive procedures.
One of the key strengths of QELC Aeris is its secure modular design, which supports detachable loading-unit use and gives surgeons practical flexibility during procedures. This modular structure also helps healthcare facilities manage procedural costs more effectively, particularly in high-volume surgical environments where device efficiency and resource utilization are important. Combined with multiple shaft lengths, including 60 mm, 160 mm, and 260 mm configurations, QELC Aeris allows surgeons to select the appropriate setup based on surgical access, anatomy, and procedural requirements.
The device also places strong emphasis on controlled tissue compression and staple line consistency. Its precision compression control is designed to support uniform jaw compression before firing, helping create more predictable conditions for staple formation. QELC Aeris further integrates Intelligent Staple Height technology, which supports staple-height matching variable tissue thickness and helps reduce unnecessary tissue stress while maintaining stable staple line formation. This is especially important in laparoscopic procedures where tissue characteristics may vary by patient, surgical site, and clinical indication.
Another important strength is the device’s Guiding Staple Technology, which supports proper staple leg alignment and B-shaped staple formation. This design helps improve closure stability and contributes to reliable staple line performance. In addition, the optimized handle-to-jaw linkage improves mechanical force transmission from the handle to the jaw, supporting smoother firing, stable compression, and controlled device handling. These engineering details work together to support the product’s core value: consistent performance in real surgical conditions, not just technical specifications on paper.
QELC Aeris also offers multiple cartridge configurations for different tissue conditions, giving surgeons practical options for intraoperative selection. This cartridge flexibility, together with the modular loading-unit design, strengthens the product’s suitability for bariatric, general laparoscopic, and other minimally invasive procedures where procedural efficiency, staple line security, and predictable performance are essential.
For Miconvey, the CE Certification of QELC Aeris is more than a regulatory milestone. It reflects the company’s continued focus on developing surgical devices that are clinically practical, quality-driven, and aligned with the needs of modern operating rooms. As laparoscopic surgery continues to expand globally, healthcare providers require solutions that balance safety, performance, usability, and economic value. With CE Certification now achieved, QELC Aeris is positioned to support wider adoption across Europe and other CE-recognized regions, strengthening Miconvey’s ability to work with surgeons, hospitals, and partners in advancing minimally invasive surgical care.
QELC Aeris - Consistency at scale
